Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback